SCHEMBL5499495

SCHEMBL5499495

COc1cc(C(N)=O)c([N+](=O)[O-])cc1OCCOc1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
LMNA P02545 4/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
RAB9A P51151 3/20 0.45
NTSR1 P30989 1/20 0.45
KMT2A Q03164 4/20 0.44
NPC1 O15118 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PKM P14618 1/20 0.44
POLB P06746 2/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 4/20 0.42
HPGD P15428 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873870 0.85 POLB (0.53) L3MBTL1LMNACASP3SENP8SENP7
SCHEMBL5502664 0.82 KDM4E (0.44) L3MBTL1LMNAKMT2ASMN1; SMN2PKM
SCHEMBL15966774 0.81 HTT (0.47) L3MBTL1LMNACASP3SENP8SENP7
SCHEMBL348156 0.80 LMNA (0.57) L3MBTL1LMNACASP3SENP8SENP7
SCHEMBL5493922 0.79 TBXAS1 (0.55) L3MBTL1LMNAKMT2ASMN1; SMN2PKM
SCHEMBL8179907 0.78 LMNA (0.43) L3MBTL1LMNACASP3SENP8SENP7
SCHEMBL15986493 0.76 HTT (0.43) L3MBTL1LMNANPC1PKMPOLB
SCHEMBL160400 0.76 MEN1 (0.57) LMNACASP3SENP8SENP7SENP6
SCHEMBL873729 0.76 MEN1 (0.57) LMNACASP3SENP8SENP7SENP6
SCHEMBL2927309 0.75 ALDH1A1 (0.54) LMNARAB9AKMT2ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed
EP-1005470-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010349-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 1999-03-04 WO disclosed